Market paradox15 Jan 2021 13:14
Last autumn i wrote "scoredagainsteps, Dest has indeed been good, one other difference between DNL and DEST is" unknown potential" crazy though it is one problem with DNL is its business potential is TOO well know, in that the market knows the deals. approvals etc markets like the unknown potential , hence DEST rise ,its the what if,,,,deals ,potential of treatments etc .Market knows DNL but should still mark up price.....thats my belief ,hence invested here,,," When i wrote this DNL was 60p approx Dest 65p approx and RENE 64p approx (my other holding in pharma stocks ) , However i now feel that DNL is not for me ,the situation has changed and having read there update again its clearly more than the placing keeping the price down ( both DEST and RENE also had placings at appox 60-70p and are now both £1.25 appox ) There note off hospitals and covid making it difficult is not going to get better in the medium term ,I had high hopes but the market and MM have a different view and its always good to review the portfolio every 3- 6 months or so , my holding now sold i wish the holders ATB and really hope the price reflects the potential someday...